MXD1 has been identified as a potential biomarker associated with specific molecular changes and tumor microenvironment characteristics in esophageal squamous cell carcinoma, but biological functions in psoriasis or immunology have been less reported [74,75]. This evidence concerns the gene MXD1 and neoplasm.